Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene Corporation (CELG) Nearly 4% Down On Better Q3 EPS, Lower-Than-Expected Revenue
Celgene Corporation (CELG) Nearly 4% Down On Better Q3 EPS, Lower-Than-Expected Revenue
Celgene Corporation (CELG) Nearly 4% Down On Better Q3 EPS, Lower-Than-Expected Revenue
Submitted by
admin
on November 5, 2015 - 9:51am
Source:
Bidness, ETC
News Tags:
Celgene
earnings
Headline:
Celgene Corporation (CELG) Nearly 4% Down On Better Q3 EPS, Lower-Than-Expected Revenue
Do Not Allow Advertisers to Use My Personal information
